Pelvic Health

Femtech Company MobileODT is Awarded a $2.3M Grant from the National Cancer Institute

MobileODT, a femtech company innovating in cervical screening, has been awarded a prestigious Small Business Innovation Research Authority grant of $2.3 million. This grant is presented by the United States National Cancer Institute (NCI) to leading companies that are technologically and clinically advanced to support the NCI’s goal of reducing suffering and death due to cancer. This grant is a tribute to the…

Detroit Medical Center Huron Valley-Sinai Hospital Introduces Sonata, a New, Incision-Free Treatment for Uterine Fibroids

Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Detroit Medical Center (DMC) Huron Valley-Sinai Hospital is the first hospital in Michigan to introduce the Sonata Procedure. Fibroids are benign growths in or around the uterus, with about 70 percent of white women and more than 80 percent of black women…

Pelvic Health Company Renovia Names New CEO and Completes Enrollment for Its Randomized Control Trial

Renovia, a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced the appointment of Eileen Maus in Q4 2020 as the company’s president and CEO. Under her leadership, Renovia completed patient enrollment in its all-virtual randomized control trial (RCT) for the leva Digital Therapeutic one month ahead of schedule. Ms. Maus is an accomplished leader in women’s health and has directed the success…

Vagiplug’s Teneha Brown: “My biggest challenge personally was pushing past the rejection, especially rejection within my immediate circle of family and friends.”

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share VagiPlug’s founding story as told by Founder Teneha Brown. Vagiplug‘s mission…

Pregna Launches CryoPop, a Carbon Dioxide (CO2) Based Innovative Cryotherapy Device to Fight Cervical Cancer

Pregna has recently announced the launch of its cryotherapy device CryoPop. The product was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device. “Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and…

Runway Growth Capital Announces a Senior Secured Term Loan of $50M to Gynesonics for Their Intrauterine Fibroid Ablation System

Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…

Northwestern Medicine Opens Comprehensive Program for Vulvar and Vaginal Health

Northwestern Medicine is now offering a specialized clinic for women with complex vulvar and vaginal conditions. Led by Rajal Patel, MD, the Comprehensive Program for Vulvar and Vaginal Health is the latest clinic integrated into the Northwestern Medicine Center for Sexual Health and Menopause. “As gynecologists we are trained to look at the inside but many women’s problems originate from the external, not internal, genitalia,”…

Rhia Ventures Invests in OCON Healthcare’s Ballerine, the First 3D Spherical Copper Intrauterine Contraceptive

Rhia Ventures has invested in Israel-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUB (Intrauterine Ball). Ballerine’s unique shape reduces irritation to the endometrium with fewer malpositions and perforations, which are significant drawbacks associated with current T-shaped IUDs. The financing will also help expand Phase II clinical trials for OCON’s SEAD product, which offers point-of-care…